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Cell death mediated through the intrinsic, Bcl-2-regulated mitochondrial apoptosis signalling pathway is critical for lymphocyte
development and the establishment of central and maintenance of peripheral tolerance. Defects in Bcl-2-regulated cell death
signalling have been reported to cause or correlate with autoimmunity in mice and men. This review focuses on the role of Bcl-2
family proteins implicated in the development of autoimmune disorders and their potential as targets for therapeutic
intervention.
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Apoptotic Cell Death and Autoimmune Disease
Apoptosis is conserved among all metazoans and in
vertebrates two main signalling pathways converge at the
level of shared cysteine-dependant aspartic acid-speciﬁc
proteases, known as caspases, that execute cell death by
the cleavage of vital cellular substrates.
1
The ‘extrinsic’ pathway to apoptotic cell death is initiated by
the ligation of so-called death receptors (DRs) on the cell
surface of a target cell with the speciﬁc ‘death ligand’ on an
opposing (immune) cell, which triggers the formation of the
death-inducing signalling complex (DISC). The tumor necro-
sis factor (TNF) family members TNF, Fas ligand (FasL/
CD95L) and TNF-related apoptosis-inducing ligand (TRAIL)
can prompt apoptosis of immune but also non-immune
cells through their cognate TNF-family receptors (R),
TNF-R1, Fas/APO1/CD95, TRAIL-RI/DR4 and TRAIL-RII/D5,
the only TRAIL-R found in mice.
2 Multimerization of trimeric
receptors leads to direct or indirect recruitment of the adaptor
protein FADD allowing for engagement and activation of
initiator pro-caspase 8 or in humans also pro-caspase 10
molecules into the DISC and subsequent activation of effector
caspases 3, 6 and 7.
2,3 The importance of this cell death
pathway that co-evolved in vertebrates with the ability to
launch an adoptive immune response, for the suppression
of autoimmunity is exempliﬁed in Fas-deﬁcient lpr
4 and
FasL-deﬁcient gld mice
5 and in patients suffering from
autoimmune lymphoproliferative syndrome (ALPS) that can
present with a variety of different pathologies and harbor
mutations either in Fas, FasL or caspase-8/10 genes,
respectively.
6 It is noteworthy that here, depending on context
and cell type, the outcome of DR-ligation is not always cell
death, but can also result in activation of the NF-kB signalling
pathway and subsequent cell survival, migration or cytokine
release.
3
The ‘intrinsic’ apoptotic pathway is induced in response to
numerous stimuli, including DNA damage, endoplasmatic
reticulum (ER)-stress, cytokine-deprivation or high-afﬁnity
ligation of antigen receptors,
7 leading to mitochondrial outer
membranepermeabilization(MOMP)thatenablestherelease
of apoptogenic factors from the inner-membrane space, most
importantly cytochrome C, triggering oligomerization of the
adapter molecule Apaf-1, leading to recruitment and activa-
tion of initiator pro-caspase 9 molecules. Subsequent
cleavage-dependent activation of effector caspases leads to
cellular demise.
7
MOMP is regulated by the complex interplay of individual
members of the Bcl-2 family that can be divided according to
their function in two subgroups. The anti-apoptotic Bcl-2
family members, Bcl-2, Bcl-xL, Bcl-w, Mcl-1 and Bﬂ-1/A1
contain up to four Bcl-2-homology (BH)-domains and localize
mainly to intracellular membranes such as ER and mitochon-
dria. The pro-apoptotic members can be further subdivided in
Bax/Bak-like proteins (Bax, Bak and Bok), containing three
BH-homology regions and the ‘BH3-only’ proteins, including
Bad, Bid, Bim, Bmf or Puma that contain only one such
homology domain. MOMP requires the pore-forming capacity
of Bax and/or Bak that act genetically downstream of
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8 Activation of Bax and Bak may either
involve their release from sequestration by pro-survival Bcl-2-
homologues, because of competitive binding of BH3-only
proteins, or their direct interaction with a subset of BH3-only
proteins,thatis,Bim,truncated(t)BidandpossiblyalsoPuma.
It is noteworthy that the intrinsic cell death pathway can
connect to the DR pathway through caspase-8-mediated
processing of the BH3-only protein Bid.
9,10
In general, apoptotic cell death under steady-state condi-
tions is poorly immunogenic because of the fast resolution
of dying cells by macrophages. Defects in the clearance
of apoptotic cells and subsequent secondary necrosis or
impaired degradation of their cellular contents by phagocytes,
for example because of loss of or reduced function of
engulfment genes such as MFG-8, complement factor C1q
or the lysosomal DNA-degrading enzyme, DNAaseII, leads to
the development of autoimmune disease in mice and men.
These observations highlight the relevance of efﬁcient corpse
clearance and cell content degradation by phagocytes for
the maintenance of tolerance (for detailed review, see
Nagata et al.
11).
The Bcl-2 Family Proteins as Barrier against
Autoimmune Disease
Although no loss of function mutations in BH3-only proteins
have been reported in patients suffering from autoimmune
diseases, overexpression of the prosurvival family members
Bcl-2,
12 Mcl-1
13 and Bﬂ-1/A1
14,15 have been noted in patients
suffering from systemic lupus erythematosus (SLE), although
not all these observations could be conﬁrmed indepen-
dently.
16 It is noteworthy that reduced levels of Bim, because
of an activating mutation in NRAS leading to accelerated
proteasomal degradation of this BH3-only protein was
associated with ALPS in one patient in which the Fas-
signalling pathway is still intact.
17 Furthermore, autoimmune
disease-associated cytokines such as IL-17 or BAFF seem to
modulate the expression levels of pro-survival Bcl-2 family
proteins, including Bcl-2
18 and Bﬂ-1/A1 in SLE-patients,
14
supporting the notion that impairment of the Bcl-2-regulated
apoptosis pathway can contribute to the rise of autoimmunity
in men. It is noteworthy that in the murine model for type I
diabetes mellitus, NOD (non-obese diabetic), thymocytes fail
to upregulate Bim on activation with high-avidity auto-antigen,
leading to impaired apoptosis in potentially auto-reactive cells
in these animals.
19 Consistently, loss of Bim or overexpres-
sion of Bcl-2 in mice triggers SLE-like disease leading to
premature lethality.
20–22
Bcl-2-Regulated Cell Death Enforces Central Tolerance
Central tolerance mechanisms enforced during early T-cell
development in the thymus ensure that only positively
selected T-cell precursors can leave for the periphery when
expressing a functional TCR that has a ‘below-threshold’
afﬁnity for self-peptide/MHC complexes (Figure 1). In con-
trast, thymocytes that lack a functional (pre)TCR die by
neglect,whereasthoseexpressingan‘above-threshold’ high-
afﬁnity TCR die by apoptosis during negative selection, both
processes regulated to a large extent by induction of different
Bcl-2 pro-survival proteins, for example, A1 and/or their
interaction with Bim, Mcl-1 or Bcl-x.
7 Loss of the BH3-only
Bim rescues double-positive (DP) thymocytes from TCR/CD3
ligation-induced apoptosis in vitro and in vivo, a phenomenon
also observed in mice overexpressing Bcl-2
23 or that lack Bax
and Bak in the T-cell lineage.
24 Furthermore, bim
 / 
thymocytes are resistant to Staphylococcus entero-
toxin B (SEB)-superantigen-induced deletion in fetal thymic
organ culture and resist negative selection in different TCR-
transgenic mouse models. For example, in transgenic mice
expressing abTCRs speciﬁc for the male HY MHC-class I
restricted antigen, double-positive thymocytes are deleted in
male but positively selected in female mice. However, in the
absence of Bim, thymocytes in male mice were rescued from
negative selection. In addition, loss of Bim protected OT-II
TCR-transgenic thymocytes from OVA (Ovalbumin)-
mediated cell death.
25 Since negative selection can still occur
at a later stage of thymocyte development at the cortical-
medullary junction of the thymus, semi-mature CD4
þ single
positive, heat-stable antigen positive (HSAþ) thymocytes
derived from Bim-deﬁcient or vav-bcl-2 transgenic mice were
analyzed in more detail and compared with thymocytes
derived from Fas-deﬁcient lpr mice or mice expressing a
dominant-negativemutantofFADD,blockingallDR-mediated
apoptosis. These studies conﬁrmed again a critical role for
Bim in negative selection while DR signalling appeared
dispensable.
26 Along the line, studies implicating TRAIL in
negative selection still await conﬁrmation.
27–29 Thus, loss of
bim or failure in Bim-induction should contribute to the
development and escape of auto-reactive T lymphocytes,
but once backcrossed onto the C57BL/6 genetic background
the autoimmune pathology originally described is strongly
ameliorated.
20,30 One possible explanation for this conun-
drum was suggested in a publication that shows that Bim-
deﬁciency in the hematopoietic systems renders mice on the
C57BL/6 background resistant to myelin oligodendrocyte
glycoprotein (MOG)-induced experimental autoimmune
encephalomyelitis and streptozotocin-induced diabetes.
31
This phenomenon was associated with an impaired ability to
activate Bim-deﬁcient T cells through their TCR, suggested to
be due to reduced calcium release and dephosphorylation
of nuclear factor of activated T cells, culminating in reduced
cytokine production. Impaired calcium release associated
with increased levels of inhibitory complexes consisting of
Bcl-2 and the inositol triphosphate receptor (IP3R), located at
the ER.
31 Interaction of Bcl-2 family proteins with the IP3R
have been reported previously and have been associated
with deregulated T-cell apoptosis (reviewed in Rong and
Distelhorst
32). In the absence of Bim (or Bax/Bak), more Bcl-2
may be available to bind IP3R at the ER, thereby reducing
calcium release and T-cell activation in response to self-
antigens, or antigens in general, but this concept awaits
independent conﬁrmation. It is noteworthy that self-reactive
T cells speciﬁc for myelin basic protein or MOG seem to be
present in comparable number in wt and bim
 /  mice,
whereas insulin-reactive T-cell clones seem to be reduced.
31
However, because of the observed impaired reactivity of Bim-
deﬁcient T cells, it is hard to judge if such auto-reactive cells
canbeactivatedeffectivelybyauto-antigenstimulationinvitro
and may actually still be present in increased numbers.
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Cell Death and DiseaseHowever, based on these observations it also seems
feasible that negative selection can effectively happen in the
absence of Bim, as supported by recent observations using
a modiﬁed transgenic mouse model, HY-TCR
cd4, in which
expression of the auto-antigen-speciﬁc TCR is timed to the
CD4
þ8
þ stage of thymocyte development, resembling more
the physiological situation than the classical HY-transgenic
mouse model. Using this model system, it was shown that
apoptosisofself-reactiveDP-thymocyteswasBim-dependent
in HY
cd4bim
 /  male mice but these animals failed to
accumulate mature CD8
þ thymocytes speciﬁc for the
auto-antigen, indicative for successful negative selection
and establishment of tolerance in the absence of Bim.
33
Furthermore,experimentsrevealedthatMMTVsuperantigen-
mediated deletion of thymocytes in H2K mice is only margin-
ally impaired in the absence of Bim.
34 These observations are
in line with observations made in recombination-dependent
Rec-HY transgenic mice in which, again, expression of the
auto-reactive TCR is timed to the onset of TCRa chain
rearrangement.
35 In this model system, self-reactive thymo-
cytes showed a CD4
loCD8
lo-activated phenotype and loss of
Bim impaired apoptosis of these cells but failed to rescue their
differentiation.Itisnoteworthythatthesecellsupregulatedthe
nuclear orphan receptor Nur77 and were ultimately deleted in
a Bim-independent manner.
35
Nur77 has been implicated in thymocyte apoptosis and
negative selection based on studies using mice overexpres-
sing a dominant-negative version of this orphan nuclear
receptor and the observation that Nur77 induction was also
found impaired in NOD mice.
36 However, Nur77
 /  mice
showed no defects in negative selection but this discrepancy
was ascribed to the fact that the dominant-negative protein
also blocks the function of related Nor-1 and Nurr1 that may
compensate for the absence of Nur77.
36 Most recently, a
unifying model for negative selection was suggested, based
on the observation that on stimulation of DP thymocytes from
lck-Bcl-2 transgenic mice with PMA and ionomycine, Nur77
and Nor-1 can translocate from the nucleus to the mitochondria,
associate with Bcl-2 and expose its BH3-only domain,
converting it into a pro-apoptotic molecule.
37,38 Consistently,
exposure of the Bcl-2/BH3-domain was also observed in
thymocytes prone to undergo negative selection in the F5 and
HY-TCR transgenic mouse models. These ﬁndings were also
used as an explanation as to why negative selection is not
impaired in Bcl-2 transgenic mice, but clearly affected in
bim
 /  mice.
25 Thus, it seems that Bim and Nur77, by
inhibition or conversion of Bcl-2, are two pro-apoptotic
effectors that converge at the mitochondria to mediate
negative selection (Figures 2 and 3), but this leaves us with
an unresolved conundrum. Why do bim
 / bcl-2
 /  mice fail to
developautoimmunedisease?Bcl-2-deﬁcientmicethatlacka
single allele of Bim are effectively rescued from polycystic
kidney disease and lymphopenia caused by loss of Bcl-2.
Loss of both alleles of bim over bcl-2 even leads to increased
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Figure 1 Selectionprocesses during T-cell development. Apoptosis contributesto the development of functional T cells various stages during T-cell development. During
early stages in the thymus cells are subjected to positive and negative selection processes. In the double-negative stage 3 the TCRb chain locus is rearranged. A functional
preTCR secures survival and allows expansion and transition to the double-positive stage in which the TCRa chain locus is rearranged. In case of TCR expression on the cell
surface, DP thymocytes interact with MHC–self-peptide complexes and can receive survival signals (positive selection). In contrast, when TCR rearrangement fails or
thymocytes receive a ‘below-threshold’ TCR signal they die by apoptosis, termed death by neglect. Negative selection assures that DP or SP
þHSA
  thymocytes expressing
an auto-reactive TCR, transmitting ‘above-threshold’ signals are eliminated. This process is mediated by induction of Bim and the nuclear orphan receptor Nur77.
Bcl-2 family proteins critically involved in these processes are indicated. Abbreviations: TCR, T-cell receptor; MHC, major histocompatibility complex;
DN, double negative; DP, double positive; SP, single positive; HSA, heat stable antigen
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Cell Death and Diseaseleukocyte numbers when compared with wt mice,
30,39 but these
cells do not seem to be auto-reactive, as evidence by the lack of
obvious autoimmune pathology in these mice (P Bouillet, pers.
communication). It remains possible that peripheral tolerance
mechanisms keep such auto-reactive cells in check in these
animals or, alternatively, that Nur77 may also convert other pro-
survival Bcl-2 homologues into killers, but the ‘conversion-
concept’ still awaits independent conﬁrmation. Therefore,
Nur77’s ability to contribute negative selection may still mainly
lieinitsprovenabilitytoregulategeneexpression.
40,41However,
it cannotbe excludedatpresentthatnegativeselectionmayalso
involve additional undeﬁned pro-apoptotic proteins or alternative
cell death mechanisms.
Development and negative selection of B cells occurs in the
bone marrow as well as in the periphery (Figure 2) and a ﬁrst
check point seems to be imposed at the preB to immature
B-cell transition in which many B-cell progenitors with an auto-
or poly-reactive pre-B BCR are cleared but found to persist in
patients with SLE or rheumatoid arthritis.
42 Auto-reactivity can
also be avoided by receptor editing but most immature B cells
formed in the bone marrow are destined to die there. B-cell
precursors that manage to rearrange their BCR properly are
subjected to negative selection at the so-called transitional T1
stageofB-celldevelopment(Figures2and3),beforeleavingfor
the periphery to complete maturation in the spleen, but are still
susceptible to negative selection processes.
42 BCR ligation-
induced apoptosis in the T1 B-cell model cell line WEHI-231,
commonly used to study negative B-cell selection can be
blocked effectively by overexpression of Bcl-xL
43 or related
Bﬂ-1/A1.
44 Transgenic expression of Bcl-2 in hematopoietic
cells rescues immature and mature B cells from BCR ligation-
induced apoptosis
45 and neutralization of Bcl-2 by Bim seems
critical for IgM-induced killing of B cells.
46 Consistently, loss of
Bim rescues immature anti-hen-egg-lysozyme (HEL) Ig trans-
genic B cells in the bone marrow from deletion in membrane-
bound (m)HEL transgenic recipient mice. In spite of the strong
evidenceforBimasacriticalregulatorofcentralB-celltolerance
not all self-reactive B cells were spared from death in this model
system in its absence, suggesting that Bim-independent
mechanisms can contribute to B-cell deletion in the bone
marrow.
46 Although non-cell death-related mechanisms, such
as anergy or proliferation deﬁcits may account for this effect, we
speculate that other BH3-only proteins, most likely Bmf, may
contribute to B-cell selection, since we observed B-cell
restricted lymphadenopathy
47 and reduced sensitivity to IgM-
induced apoptosis in selected B-cell subsets in bmf
 /  mice
(AV, unpublished). Our speculation is supported by the fact that
B-cell restricted loss of both Bax and Bak protects B cells more
potently from IgM-induced killing than loss of Bim and causes
rapid onset of autoimmune disease in these mice.
48 Although
animals lacking both Bim and Puma do also show an
accumulation of mature B cells, IgM-mediated killing of B cells
seemed entirely Bim-dependent in these double-deﬁcient
animals, excluding Puma as a putative effector during B-cell
selection.
49 Consistently, bim
 / puma
 /  mice fail to develop
signs of autoimmune pathology that exceed those noted in Bim-
deﬁcient animals but show an increased incidence of sponta-
neously arising diffuse large B-cell lymphomas.
49
Figure 2 Selection processes during B-cell development. To secure survival of functional B cells, progenitors are subjected to stringent selection in the bone marrow, but
also later in the periphery. Rearrangement of the immunoglobulin (Ig) heavy (H) gene locus in during pro/pre-B-cell transition secures survival and expansion of cells that
express a functional preBCR on the cell surface, while others die by neglect. Late stage preB cells start to rearrange their Ig light (L) gene loci. IgM expressing immature
transitionalBcellsaresubjectedtonegativeselectioninthebonemarrowbeforeﬁnishingtheirmaturationinthespleen.There,Bcellsareagainscreenedforautoreactivity,for
example,arisingduringgerminalcenterreactions,andcan beeliminated.Alternatively,theycanmatureintoIg-secretingplasmacellsormemoryBcells.Bcl-2familyproteins
critically involved in these processes are indicated in the appropriate locations. Abbreviations: BCR, B cell receptor; T, transitional; M, mature; Mm, memory cell B cells; PB,
plasmablast; PC, plasma cell
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Cell Death and DiseaseIn summary, whereas the contribution of the extrinsic
pathway for the establishment of central tolerance remains
controversial, the intrinsic Bcl-2-regulated apoptosis pathway
is clearly pivotal for this process. Bim seems the key player in
this event and so far little experimental evidence exists that
other members of the BH3-only subgroup, although clearly
co-regulatinglymphocytehomeostasistogether withBim,
49,50
can contribute to negative selection during the establishment
of central tolerance.
Maintenance of Peripheral Tolerance by Apoptotic
Cell Death
In spite of the stringency of negative selection, some auto-
reactive T cells can escape into the periphery and low-afﬁnity
interactions between auto-antigens and antigen-receptors
may actually contribute to lymphocyte survival.
42 Escapees of
central tolerance mechanisms may be kept in check by the
induction of anergy, receptor editing and/or regulatory
T (Treg). However, such cells can become activated by
pathogenic epitopes with high similarity to peripheral auto-
antigens, for example, during chronic infection and inﬂamma-
tion. After traumatic injury, increased cell death rates in
affected tissues can result in insufﬁcient uptake of necrotic
cells, thereby facilitating the release/exposure of self-anti-
gens, such as nuclear proteins or ribonucleic acids. Similarly,
continuous exposure to environmental factors or prolonged
drug-treatment can lead to the generation of ‘neo-self-
epitopes’ that can activate auto-reactive lymphocytes.
One possibility to eliminate peripheral auto-reactive T cells
is mediated by cross-presentation of self-antigens by APCs in
secondary lymphoid organs. Under non-inﬂammatory condi-
tions potentially auto-reactive T cells recognize self-antigen
Figure 3 Regulation of peripheral tolerance by the intrinsic and extrinsic apoptosis pathways in T and B cells. Both apoptosis pathways cooperate to eliminate no longer
functional or required activated T and B lymphocytes in peripheral lymphoid organs. Under non-inﬂammatory conditions T cells recognizing self-antigen presented by APCs
undergoapoptosisaftercross-presentationthatismediatedbytheintrinsicapoptosispathwaybyinductionoftheBH3-onlyproteinBim.Incontrast,whenacuteviralinfections
induce strong TCR signals or when they are becoming chronic the extrinsic pathway by Fas–FasL interaction (either in an autocrine or paracrine manner) is required for
elimination of activated T cells. The intrinsic pathway contributes to the termination of both, acute as well as chronic immune response because of activation on cytokine-
deprivation.Duringafﬁnitymaturationingerminalcenters,theintrinsicandextrinsicpathwaycooperatetoselectBlymphocytesexpressinghigh-afﬁnityBCRs.InB-cellclones
that receive insufﬁcient stimulation by their low-afﬁnity BCR, anti-apoptotic Bcl-2 protein family members (e.g., Bcl-2, A1) drop. This response is accompanied by a reduced
levelofNF-kBactivationleadingtoreducedFLIP-levels,intheabsenceofCD40signals,makingthemmoresusceptibletoFas/FasL-inducedapoptosis.Incontrast,ligationof
high-afﬁnity BCRs increases the amount of pro-survival molecules of the Bcl-2 family, as well as NF-kB and FLIP, resulting in increased resistance to cell death. After
eliminationofthepathogen,adropofsurvivalfactorsorFcgRIIbligationcanactivateBH3-onlyproteinssuchasBimandmaybePumaandBmftosecureclearanceofplasma
cells. This can be counteracted by cytokines such as BAFF that lead to up-regulation of anti-apoptotic Bcl-2 family proteins like Bcl-2, Bcl-xL and A1. Abbreviations: APC,
antigen presenting cell; BCR, B-cell receptor; BAFF, B-cell activating factor of the TNF family; NF-kB, nuclear factor ‘kappa-light-chain-enhancer’ of activated B cells;
FLIP, FLICE-like inhibitory protein
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Cell Death and Diseasepresented by DCs, are stimulated to proliferate but then
undergo apoptosis. Proteins of the Bcl-2 family are crucial for
the induction of cross-presentation initiated cell death
because in a model of self-tolerance in which OVA was
expressed selectively in pancreatic -cells, overexpression of
Bcl-2orlossofBimpreventeddeletionofCD8
þ OVA-reactive
T cells, implicating a role of both in mediating cross-
tolerance.
51 Consistently, loss of Bim also rescued DO11
TCR
þ CD4
þ T cells from deletion on transfer into sOVA
transgenic recipients, but surviving bim
 /  T cells were
rendered anergic, questioning the relevance of apoptotic cell
death as a unique mechanism for the establishment of
peripheral tolerance to systemic self-antigens.
52
After pathogens have been successfully eliminated by the
immune system most effector cells are removed by induction
of apoptosis whereas only few differentiate into memory cells.
This deletion process is crucial for maintaining lymphocyte
homeostasis and the prevention of autoimmunity, for exam-
ple, by limiting production of inﬂammatory cytokines. Both,
the intrinsic and extrinsic apoptosis pathways were controver-
sially discussed to regulate the shutdown of immune
responses but the relative importance of each signalling
pathway seems to rely on the type of antigen encountered.
53
Control of Peripheral T-Cell Tolerance – Lessons from
Bim-Deﬁcient lpr Mice
In response to antigens that trigger an acute T-cell response,
for example, herpes-simplex-virus type 1 (HSV-1) or super-
antigens such as SEB, depletion of activated T cells in the
termination phase of the immune response is blocked by
overexpression of Bcl-2 and requires Bim,
53,54 and in some
settings Puma,
55 upstream of Bax and Bak. In spite of the
initial reports involving the Fas/FasL system in this event,
numerous studies have shown that DR signalling is dispen-
sable for this process (reviewed in Strasser et al.
3 and
Pellegrini et al.
53). This, however, contrasted the fact that
Fas-deﬁcient lpr and FasL-deﬁcient gld mice develop overt
autoimmunity characterized by the appearance of abnormal
CD4
 CD8
  abTCR
þB220
þ T cells that seem to be derived
from persisting effector T cells that downregulated their
surface marker expression.
3 As mentioned, autoimmunity in
humans can be directly linked to mutations in components of
the Fas/FasL/caspase-8 axis in ALPS patients that can be
classiﬁed according to genotype as type Ia, Ib and II,
corresponding to germline mutations in Fas, FasL and
caspase-8 or 10, respectively.
6 However, reduced levels of
Bimproteinhavebeenreportedtoaccountforautoimmunityin
an ALPS patient that did not show defects in Fas signalling
(ALPS type III). An activating NRAS mutation, resulting in
enhanced ERK signalling and a marked reduction in Bim, was
identiﬁed as the underlying molecular mechanism, leading to
the elevated numbers of TCRab CD4
 8
  T cells and chronic
lymphoid accumulation.
17 Thus, disturbances in the intrinsic
as well as extrinsic pathway may enforce the development of
autoimmunity because of ineffective elimination of effector
lymphocytes during the shutdown of immune responses,
a notion already suggested in early studies on lpr
mice expressing transgenic Bcl-2.
56 How do both path-
ways contribute to the induction of apoptosis in activated
lymphocytes after successful removal of pathogens? One
simple explanation might be that upon clearance of the antigen
production of pro-survival cytokines ceases, resulting in the
Bcl-2-regulated death of activated lymphocytes. Cytokine-
deprivation-induced celldeathismediated byBimand Puma,
57
but not by the extrinsic pathway.
3,53 This, however, fails to
explain the increased number of lymphocytes as well as the
development of autoimmunity in mice and humans suffering
from ALPS type I or II. More recent studies indicate that both
pathways contribute and cooperate to shutdown immune
responses depending on the type and strength of the antigen
encountered. Using mice deﬁcient in both, Bim and Fas, it was
convincingly shown that deletion of effector T cells after an
acuteviralinfectionwithHSV-1wassolelydependentonBim,
58
whereas shutdown of a chronic infection elicited by infection of
these mice with mouse–herpes virus (MHV-68)was dependent
on both Bim and Fas.
58 This indicated different requirements of
theintrinsicandextrinsicpathwayforT-celldeletion,depending
on acute versus chronic infections. The latter ﬁnding is
consistent with the fact that auto-antigens can be considered
as chronicand persistent antigens and inline withobservations
that re-stimulation of the TCR on activated T cells is required to
drive expression of FasL triggering autocrine T-cell suicide or
fratricide.
2 It is noteworthy that another group studying clonal
contraction of T cells after acute lymphocytic choriomeningitis
virus (LCMV) infection also showed cooperation of Bim and
Fas-mediated cell death, contrasting results using the HSV-1
model.
59 However, one explanation for the noted difference
may be that HSV-1 and LCMV epitopes provide different
strength of signals to the reactive TCRs resulting in different
activation levels of these effector molecules and types of
immune responses. Consistent with these observations, Bim
and Fas-deﬁciencies also cooperate in the induction of
autoimmunity very early in age, accompanied by massive
accumulation of leukocytes that can make up to half of the
animal’sbody mass. Also unusual abTCR
þCD4
 CD8
 B220
þ
T cells were observed on the pure C57BL/6 background, in
which normallyneitherlossofBimnorFasleads topronounced
autoimmune pathology.
58 Thus, both the intrinsic as well as
the extrinsic pathway are responsible for the elimination of
effector T cells during the retraction phase of immune
responses thereby preventing development of autoimmunity
(Figure 3).
Maintenance of Peripheral B-Cell Tolerance
B cells are also subjected to selection processes in the
periphery on encounter of self-antigen. In the anti-HEL
Ig/soluble (s)HEL autoimmune model, it has been shown that
Bim levels are increased in BCR-transgenic B cells on
encounter of the self-antigen
60 and it has been suggested
that the increased availability of BAFF (BlyS/TNFS13) on a
per B-cell basis allows persistence of such auto-reactive cells
in the double-transgenic mice that would otherwise die or are
rapidly outcompeted by normal B cells.
60 Consistently, Bim-
deﬁciency or Bcl-2 overexpression rescues auto-reactive
B cells from deletion in the periphery of this model of negative
B-cell selection.
46 Furthermore, anergic B cells in such anti-
HEL Ig/sHEL transgenic animals can become reactivated and
secrete anti-HEL immunoglobulin if they lack Bim because
Bcl-2 family proteins and tolerance
D Tischner et al
6
Cell Death and Diseasethey no longer depend on BAFF for survival but remain
receptive for its differentiation signals.
61 BAFF, produced
mainly by innate immune cells and known to be critical for the
survival of type 2 (T2) transitional and mature B cells, binds
three receptors, TACI (transmembrane activator and calcium
modulator and cyclophilin ligand interactor), BCMA (B-cell
maturation antigen) and the BAFF-receptor (BAFF-R)
(reviewed in Mackay and Schneider
62). Signalling along the
latter has been reported to counteract BCR ligation-induced
accumulation of Bim and apoptosis in WEHI-231 cells,
63 as
well as a number of prosurvival molecules including Bcl-2,
Bcl-xL and Bﬂ-1/A1, the latter most potently in conjunction
with IL-17.
14,62 All these prosurvival Bcl-2 family members
potently block BCR-induced apoptosis in primary B cells or
B-cell lines, but also cell death triggered by a number of other
stimuli that are not mediated by Bim. Therefore, inhibition
of Bim-accumulation on BCR-ligation may be only one aspect
of (aberrant) B-cell survival inﬂicted by access BAFF, which
may contribute to auto-immunity. BAFF transgenic mice show
B-cell restricted hyperplasia affecting mainly T2 and mature
marginal zone as well as follicular B cells.
18,64 The arising
autoimmunity in these mice resembles human SLE and
Sjo ¨grens syndrome and it was suggested that this might be
due to increased survival of auto-reactive B cells due a BAFF-
driven increasein Bcl-2 protein levels.
64 The B-cell phenotype
of BAFF transgenic mice is similar to that observed in Em-bcl-
2-22 transgenic mice, in which expression of the transgene
was limited to the B-cell lineage, or bim
 /  mice,
20,21 which
highlights the connection between BAFF signalling and
selection processes regulated by Bcl-2 family proteins.
An increased level of autoantibodies and the formation of
immuncomplexes is a prominent feature of SLE in humans.
Also Bim-deﬁcient mice on a mixed 129SV-C57BL/6
background develop severe autoimmunity with SLE-like
symptoms. Bim
 /  mice suffer from splenomegaly and
lymphadenopathy resulting from two to four times increased
numbers of lymphoid cells. In old mice the amount of
IgG-secreting B cells was 200-fold augmented accompanied
by a 10-fold increased level of IgG as well threefold of IgA and
IgM. This suggests that Bim may become activated once the
antigen has been cleared and survival factors become limiting
for Ig-producing plasma cells or on ligation of FcgRIIb
receptors, an inhibitory Fc-receptor expressed on the cell
surface of B cells.
65 It is noteworthy that the number of low-
afﬁnity Ig-expressing memory B cells was augmented in
bim
 /  mice indicating an important role of Bim in the elimi-
nation of low-afﬁnity Ig-bearing B lymphocytes during germinal
center reactions.
66 A similar phenotype was observed in Bcl-2
overexpressing mice but there the amount of serum Ig levels
and the number of antigen-speciﬁc B cells was even more
increased,
66 suggesting a possible contribution of other
BH3-only proteins, possibly Bmf or Puma. It is noteworthy that
bim
 / puma
 /  mice show a selective increase in IgA plasma
levels that is comparable to the one observed in vav-bcl-2
transgenic mice implicating Puma in the survival of class-
switched long-lived IgA-secreting plasma cells.
49
In spite of the documented relevance of the intrinsic
apoptosis pathway for the deletion of peripheral B cells it
remainsfactthatBcellsaresusceptibletoFas-inducedkilling.
This death is most effectively blocked when BCR and CD40
become activated simultaneously, leading to enhanced
expression of c-FLIP through NF-kB signalling, for example,
in germinal center B cells during afﬁnity maturation.
67,68
There,onlyB-cellcloneswithhighestafﬁnityfortheantigendo
survive while others die by neglect. Deletion of sub-optimal
B-cell clones that do not receive a sufﬁciently strong survival
signal through their BCR and CD40 molecules also involves
Fas-mediated killing through CD4
þ intra-follicular helper
T cells expressing FasL.
69 One can envision a scenario in
which insufﬁcient BCR-signalling because of low-afﬁnity
antigen-recognition may lead to a drop in expression levels
of pro-survival molecules such as Bcl-2 or Bﬂ-1/A1, sensitiz-
ing to BH3-only protein-regulated cell death while lack of
CD40-ligation renders these cells susceptible to Fas-ligation,
because of lack of NF-kB signalling culminating in low-level
expression of c-FLIP. Why both mechanisms may be
activated or are required to secure deletion of low-afﬁnity
B-cell clonesremainsunclearatpresent,but,asinTcells,this
may depend on the type of antigen encountered.
70 Consis-
tently, experiments assessing the deletion of auto-reactive
B cells that may arise in germinal centers, for example, during
receptor editing, again support the notion that both pathways
are critical for the elimination of such cells.
69
In summary, while the contribution of the extrinsic pathway
for the establishment of central tolerance remains controver-
sial, both the extrinsic Fas/FasL and the intrinsic Bcl-2-
regulated apoptosis are clearly pivotal for the maintenance
of peripheral T- and B-cell tolerance. This notion is also
supported by the vast and aggressive autoimmunity observed
in bim
 / lpr mice.
13,58,59 Bim seems the key player in this
event and so far little experimental evidence exists that other
members of the BH3-only subgroup, although clearly co-
regulating lymphocyte homeostasis together with Bim,
49,50
are critical for the maintenance of peripheral tolerance.
Cell Death of APCs is Critical to Preclude Autoimmunity
In spite of the massive lymphadenopathy and documented
defects in activated T-cell apoptosis in Bim-deﬁcient lpr mice,
it remains uncertain which cell type is the most critical
determinant triggering exacerbated autoimmunity in these
mice. Elegant studies using cell type restricted deletion of the
Fas gene clearly showed that loss of Fas on DCs, which
induce expression of this DR on exposure to microbial stimuli,
issufﬁcienttocausesystemicautoimmunityinmice.
71Hence,
apoptosis of mature DCs by FasL-expressing activated
antigenic T cells restricts their lifespan and thereby limits the
duration of an immune response through a negative regula-
tory loop. Similarly, deletion of Fas in B cells causes
autoimmunity, presumably because Fas-sensitive antigen-
presenting B cells persist and sustain survival of self-reactive
T cells that are usually deleted in a Fas-dependent manner.
71
In contrast, it is still unclear which cell type is most critical for
establishing autoimmunity in Bim-deﬁcient animals on the
mixed genetic background
20 and cell type-speciﬁc deletion
of bim may reveal interesting novel insights. However, one
can assume that Bim, targeted by TLR-signalling in APCs,
prevents autoimmunity also by limiting the lifespan of DCs.
Bim-deﬁcient DCs show reduced apoptosis and allow more
sustained T-cell responses in vitro and in vivo. Furthermore,
Bcl-2 family proteins and tolerance
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induce auto-antibody production in recipient mice on chal-
lenge with LPS.
72 Hence, it will be interesting to determine at
which cellular level, Bim and Fas exert highest levels of
synergy to preclude autoimmunity by combining conditional
knockout models available for both genes.
Effect of Cell Death on Treg Cell Homeostasis and Function
Next to the induction of apoptosis and anergy, Treg cells are
thekey-regulatorsofperipheraltolerance.
73Tregcellsarisein
the thymus (natural Treg cells) and are characterized by the
expression of cell surface markers such as CD4, the IL-2
receptor a-chain, CD25, the TNF-R family members CD134
and GITR and the cytotoxic T-lymphocyte antigen-4
(CTLA-4).
74 As these molecules can also be found on other
cells only the transcription factor FoxP3 serves as reliable
marker for Treg cells.
75,76 In the absence of FoxP3 mice
develop the scurfy phenotype and humans suffer from IPEX
(immunodysregulation, polyendocrinopathy, enteropathy,
X-linked) that is characterized by an ALPS and inﬁltration of
multiple organs by activated CD4
þ T cells.
77 Furthermore,
many autoimmune disorders are associated with a reduced
function or decreased survival of Treg cells.
78,79 Consistently,
timed deletion of Treg cells causes severe autoimmunity in
mice.
80 Thus, the survival capacity of Treg cells and factors
that affect on it are critical for the prevention of autoimmunity.
However, mechanisms that control Treg survival remain
controversial and poorly understood (Figure 4).
Apoptosis as a Regulator of Treg Cell Maturation and
Function
Contrary to conventional CD4
þFoxP3
  T cells, Treg cells are
unableto produce IL-2bythemselves becauseFoxP3 impairs
IL2 transcription. Although Treg viability can be increased by
other cytokines signalling through receptors containing the
common (c) chain (e.g., IL-7, IL-15, IL-21), IL-2 is the most
potent and represents their key survival factor.
81 Although the
development and function of Treg cells in IL-2- and CD25-
deﬁcient mice is not impaired, their number in the periphery is
strongly reduced leading to ALPS, as observed in scurfy
mice.
82 Furthermore, in murine autoimmune disease models
the Treg:Teffector cell ratio was reduced because of IL-2-
deprivation and in a diabetes mouse model this resulted in a
diminished expression of Bcl-2 in Treg cells, indicative for
increased apoptosis susceptibility.
83 The BH3-only proteins
Bim and Puma determine the sensitivity of T cells to cytokine
withdrawal-induced cell death by neutralizing Bcl-2 and Mcl-
1.
55,57Consistently,TcellsfromBim-deﬁcientanimalsormice
overexpressing Bcl-2 are more resistant to cytokine-depriva-
tionandwenotedthatintheseanimalsthepercentageofTreg
cells, in particular of the CD4
þCD25
  subset, is signiﬁcantly
increased. Although Puma can contribute to apoptosis
induced by IL-2-deprivation in T cells
55,57 and the elimination
of antigen-activated T cells after acute viral infection,
84 Treg
cell numbers seem normal in puma
 /  mice (AV and DT,
unpublished).
Increased Bcl-2 expression levels may also account for the
reported resistance of Treg cells to glucocorticoids (GCs)
when compared with conventional CD4
þ T cells,
85 maybe by
bufferingGC-mediatedinductionofBimandBmf,asobserved
in leukemia cells,
86 or Puma, as noted in mouse thymo-
cytes.
87 It is noteworthy that multiple sclerosis and SLE
patients are commonly treated with GCs and in these patients
anaccumulation ofTregcellswasobserved onGC-therapy.
88
In contrast, Treg cells are more susceptible to g-irradiation
89
and cyclophosphamide-mediated cytotoxicity,
90 the latter
may account for the accelerating effect of this drug on the
development of type I diabetes in animal models. Apoptosis
induced by g-irradiation or DNA-damaging drugs in lympho-
cytes is mainly mediated by Puma
87 and it will be interesting
to see if Treg cells show stronger induction of Puma on
DNA damage when compared with conventional T cells. In
contrast, to naı ¨ve conventional CD4
þ T cells, Treg cells are
highly susceptible to FasL-mediated cell death that may be
explained by higher expression levels of Fas on their
surface.
91 Consistent with a role for the Fas/FasL system in
Treg cell homeostasis, their number seems increased in
FasL-deﬁcientgldmice,
92anobservationactuallyatoddswith
the observed autoimmunity in these animals, but one study
also reported inefﬁcient Treg cell activation by APCs in
MRL/lpr mice that may explain this discrepancy.
93
Apoptosis as a Means for Treg cells to Suppress
Effector Cells
Next to Treg cell homeostasis, survival factors also affect on
Treg cell-mediated suppression of immune responses. Treg
cells suppress other leukoytes by different mechanisms: This
includes inhibition of dendritic cells by CTLA-4, the secretion
Figure4 ApoptosisandTregcellhomeostasisandfunction.ApoptosisaffectsonTregcellsurvivalandfunctionatmultiplelevels.Tregcellapoptosissusceptibilityinresponse
toGCs isdecreasedbutincreasedinresponsetocytokine withdrawal,g-irradiation,cyclophosphamideandFas–FasL interaction,when comparedwith conventional CD4Tcells.
In addition, Treg cells mediate their suppression of immune responses in part by induction of apoptosis (cytolysis, cytokine consumption or expression of DR-ligands)
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metabolic disruption of other leukocytes, for example, by
transfer of inhibitory cAMP through gap junctions.
94 However,
also the induction of apoptosis in effector cells by the release
of granzymes
95 or expression of death ligands, for example,
FasL or TRAIL, belongs to the key mechanisms used by Treg
cells to mediate suppression.
96–98 As mentioned above, Treg
cells are unable to produce IL-2 by themselves but rely on this
cytokine for survival. Hence, IL-2 consumption has been
suggestedasameansusedbyTregcellstokilleffectorTcells
during later stages of their activation.
99 This model was
supported by the observation that Bim-deﬁcient CD4
þ T cells
were less susceptible to Treg cell induced apoptosis and wild-
type responder cells showed reduced levels of phosphory-
latedAktandtheinactivephopho-formoftheBH3-onlyprotein
Bad when co-cultured with Treg cells.
99 However, another
study using human Treg cells suggested that IL-2 depletion
alonewasnotsufﬁcienttosuppresseffectorTcells.
100Hence,
a more detailed analysis of the role of Bcl-2 family proteins in
Treg cell function seems warranted to resolve these issues.
Targeting the Bcl-2-Regulated Apoptosis Pathway for
Autoimmune Therapy
In summary, Bcl-2 family proteins are most critical for the
establishment and the maintenance of self-tolerance.
Pro-inﬂammatory cytokines such as IL-6 or IL-17 as well as
criticalB-cellsurvivalfactorssuchasBAFF,whenproducedin
excess, can contribute to loss of tolerance and autoimmunity,
in part by raising levels of pro-survival Bcl-2 family members
or,alternatively, by reducingthe levels or function of BH3-only
proteins in effector cells, leading to a breach of tolerance.
Hence, it seems feasible that the use of BH3-mimetics,
compounds that mimic the action of BH3-only proteins,
designed to overcome deregulations of the Bcl-2 rheostat
for the treatment of cancer, may become also a useful tool for
the treatment of autoimmune disorders. Studies using animal
models of collagen-induced arthritis and IFN-a-induced lupus
nephritisactuallyalreadyprovideproveofconcept.Treatment
of mice with the BH3-mimetic ABT-737 clearly delayed onset
and severity of these induced autoimmune disorders, pre-
sumably by limiting antigen-speciﬁc lymphocyte survival and
proliferation.
101 Why antigen-activated or mitogen-treated
cycling lymphocytes are more susceptible to ABT-737 than
restingones remains to be clariﬁed. In addition, a recent study
provided evidence that delivery of a cell-permeable Bim-BH3-
domain peptide effectively ameliorated autoimmune symp-
toms in an experimental arthritis model in mice by inducing
apoptosis of myeloid cells in the joints of challenged
animals,
102againsuggestingthatBH3-mimetics maybecome
useful tools to treat autoimmune disorders. Hence, it will
be interesting to see if and how BH3-mimetics improve the
efﬁcacy of drugs currently used to treat autoimmune
symptoms.
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